Quantum Biopharma (QNTM) Tax Provisions (2019 - 2026)

Quantum Biopharma (QNTM) posted Tax Provisions of -$13.8 million for Q1 2026, down 189.7% sequentially from -$4.7 million in Q3 2025, and down 57.37% YoY from -$32.3 million in Q1 2025.

Quantum Biopharma (QNTM) Tax Provisions (2019 - 2026) Analysis & Trends

Quantum Biopharma (QNTM) has 6 years of Tax Provisions data on file, last reported at -$13.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn -
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -859,000.00
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 31.86 Mn
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 221.50 Mn
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn -459,000.00
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 104.00 Mn
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 60.00 Mn
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 15.66 Mn
9 Revolution Medicines 37.15 Bn 37.15 Bn - -
10 Quantum Biopharma 15.08 Mn 8.50 Mn - -13.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.75 Mn
Sep 30, 2025 -4.75 Mn
Jun 30, 2025 -9.77 Mn
Mar 31, 2025 -8.74 Mn
Sep 30, 2024 -4.02 Mn
Jun 30, 2024 -3.35 Mn
Mar 31, 2024 -2.09 Mn
Sep 30, 2023 -1.13 Mn
Jun 30, 2023 -5.49 Mn
Mar 31, 2023 -9.96 Mn
Mar 31, 2020 -8.07 Mn
Mar 31, 2019 -1.73 Mn